Press Releases

OVER £175 MILLION FOR CUTTING-EDGE GENOMICS RESEARCH TO HELP BOOST DIAGNOSIS AND TREATMENT FOR PATIENTS

Genomics England has announced funding of £105 million to kickstart a world-leading research study, in partnership with the NHS, to explore the effectiveness of using whole genome sequencing to find and treat rare genetic diseases in newborn babies.

New startup Graegis Pharmaceuticals to prevent skin and mucosa side effects of radiotherapy

Graegis Pharmaceuticals has announced its plan to start proof-of-concept clinical trials in 2023 in the prevention of radiation-induced dermatitis and mucositis.

CLINICAL REFERENCE MATERIALS TO SUPPORT TOTAL CHOLESTEROL, HDL, AND LDL ASSAYS

CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis

Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process

Creative Proteomics Lipidomics Launches Ceramides Analysis Service

Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

Diagnostics for the Real World’s landmark SAMBA machine enters Science Museum Group’s permanent collection and features in major new “Injecting Hope” exhibition

Diagnostics for the Real World (DRW), innovator of the SAMBA platforms for rapid point-of-care detection of infectious diseases, today announces that the SAMBA device will be on public display at the Science Museum’s major new free exhibition “Injecting Hope: The race for a COVID-19 vaccine”, which runs from 30 November 2022 – 07 January 2024.

Biopharma PEG Develops PEG Products For Click Chemistry

Huateng Pharma Supplies Semaglutide Intermediates Against Type 2 Diabetes

FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS

Creative Enzymes Provides DNA Molecular Weight Markers and Ladders

CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing

MicrobioSeq Boosts Scientific Research with Gene Expression Analysis

Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas

Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics

Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media

Creative Bioarray Releases GMP Grade Cytokines to Support Cell Manufacturing and Cell-based Therapies

Acroscell Develops CiPA in Silico Modeling to Identify and Optimize Drug Candidates

Chantal van Gils joins NDA Advisory Board as Director of Epidemiology and Real-World Evidence

NDA Group has announced that Chantal van Gils NDA, MD, Ph.D., specialist in epidemiological analyses and outcome research, joins the NDA Advisory Board as Director of Epidemiology and Real-World Evidence.